Services A-Z     Pricing

Regulatory Blog

19 May 2021

eSports vs. the Law

Gone are the days of computer gaming being viewed as a secluded activity; gaming is now a thoroughly social experience that attracts a global audience of millions and players can compete for large sums of money and celebrity. This burgeoning industry is largely in a virtual world and has developed in a blockchain, decentralised fashion. Often the UK government talks up the UK gaming industry and how keen the government is to support this sector, and there have been instances that show support, but when it comes to playing games competitively, law and regulations have not yet caught up.

Robert Houchill

13 May 2021

Preventing solicitor burn-out: more than ‘just an HR issue’

Failing to promote a good workplace culture based upon a firm’s core values is a potential regulatory issue.

Julie Norris

12 May 2021

One Year On: Care Sector Challenges Arising from COVID-19

In this article, the first of three in a series, we focus on how the vulnerability of the care sector population, the availability of Personal Protective Equipment (‘PPE’) and comprehensive testing, and chronic workforce pressures have contributed to the scale and severity of the impact of COVID-19 in the care sector.

Shannett Thompson

28 April 2021

Dr Richard Freeman is struck off – but the saga for British Cycling continues

Dr Freeman, who was previously the chief doctor at both British Cycling and Team Sky has been found to have ordered testosterone patches “knowing or believing” they were for the purpose of improving athletic performance. In light of their findings, a Panel of the Medical Practitioners Tribunal Service (MPTS) held that Dr Freeman’s fitness to practise was impaired, and ordered that his name be erased from the General Medical Council (GMC) register.

Shannett Thompson

28 April 2021

Guidance on cannabis-based medicinal products receives important clarification

In September 2020 we reported in our blog on the First NHS Prescription for a Child’s Cannabis Medicine that a challenge to the National Institute for Health & Care Excellence (NICE) Guidelines on cannabis-based medicinal products (CBMPs) was being brought by way of judicial review (JR) by the family of Charlie Hughes. It was reported earlier this week that the legal challenge has now been dropped, following an important ‘clarification’ of the NICE Guidelines.

 
Shannett Thompson

Skip to content Home About Us Insights Services Contact Accessibility